166 related articles for article (PubMed ID: 29771769)
1. Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis.
Brunetti O; Aprile G; Marchetti P; Vasile E; Casadei Gardini A; Scartozzi M; Barni S; Delfanti S; De Vita F; Di Costanzo F; Milella M; Cella CA; Berardi R; Cataldo I; Scarpa A; Basile D; Mazzuca F; Graziano G; Argentiero A; Santini D; Reni M; Cascinu S; Silvestris N
Pancreas; 2018 Jul; 47(6):759-771. PubMed ID: 29771769
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
Stotz M; Eisner F; Szkandera J; Absenger G; Kornprat P; Lackner C; Samonigg H; Gerger A; Pichler M
J Clin Pathol; 2013 Sep; 66(9):753-7. PubMed ID: 23750038
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.
Luo G; Fan Z; Gong Y; Jin K; Yang C; Cheng H; Huang D; Ni Q; Liu C; Yu X
Pancreas; 2019 Jul; 48(6):817-822. PubMed ID: 31210663
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
[TBL] [Abstract][Full Text] [Related]
5. The Italian Rare Pancreatic Exocrine Cancer Initiative.
Brunetti O; Luchini C; Argentiero A; Tommasi S; Mangia A; Aprile G; Marchetti P; Vasile E; Casadei Gardini A; Scartozzi M; Barni S; Delfanti S; De Vita F; Di Costanzo F; Milella M; Cella CA; Berardi R; Cataldo I; Santini D; Doglioni C; Maiello E; Lawlor RT; Mazzaferro V; Lonardi S; Giuliante F; Brandi G; Scarpa A; Cascinu S; Silvestris N
Tumori; 2019 Aug; 105(4):353-358. PubMed ID: 30967031
[TBL] [Abstract][Full Text] [Related]
6. [Report of two clinical-pathological cases of pancreatic intraductal papillary neoplasms with distinct phenotype and outcome].
Pérez Rojas J; Artes MJ; Prieto Rodríguez M; Moya Herraiz AA; Guarín Corredor MJ; López Valdivia C; Vera Sempere JF
Gastroenterol Hepatol; 2015 Feb; 38(2):71-4. PubMed ID: 24837042
[No Abstract] [Full Text] [Related]
7. [Clinicopathological aspects of pancreatic cancer].
Egawa S; Sunamura M; Abe H; Motoi F; Fukuyama S; Matsuno S
Gan To Kagaku Ryoho; 2005 May; 32(5):605-11. PubMed ID: 15918558
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Intraductal Papillary Mucinous Neoplasm-Derived Cancer, Mucinous Cystic Neoplasm-Derived Cancer, and Adenocarcinoma: National Survival Outcomes.
Ramai D; Barakat M; Lai JK; Gao ZH; Dhaliwal A; Abdelfatah MM
Pancreas; 2020 Oct; 49(9):e88-e90. PubMed ID: 33003096
[No Abstract] [Full Text] [Related]
11. [Clinicopathologic review of 41 cases of pancreatic mucinous cystic neoplasms].
Kim JC; Kim MH; Lee TY; Kim JY; Han JH; Park SJ; Lee SS; Seo DW; Jang SJ; Lee SK
Korean J Gastroenterol; 2008 Jan; 51(1):34-9. PubMed ID: 18349560
[TBL] [Abstract][Full Text] [Related]
12. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
Scarlett CJ; Salisbury EL; Biankin AV; Kench J
Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing Regimens.
Takahashi H; Ikeda M; Shiba S; Imaoka H; Todaka A; Shioji K; Yane K; Kojima Y; Kobayashi S; Asagi A; Ozaka M; Takada R; Nagashio Y; Horiguchi S; Kasuga A; Suzuki E; Terashima T; Ueno M; Morizane C; Furuse J
Pancreas; 2021 Jan; 50(1):77-82. PubMed ID: 33370026
[TBL] [Abstract][Full Text] [Related]
14. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
15. Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
Bisht S; Brossart P; Feldmann G
Oncol Res Treat; 2018; 41(10):590-594. PubMed ID: 30286472
[TBL] [Abstract][Full Text] [Related]
16. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.
Lüttges J; Klöppel G
Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic ductal adenocarcinoma: metastatic disease.
Muñoz Martín AJ; Adeva J; Martínez-Galán J; Reina JJ; Hidalgo M
Clin Transl Oncol; 2017 Dec; 19(12):1423-1429. PubMed ID: 28623515
[TBL] [Abstract][Full Text] [Related]
18. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
[TBL] [Abstract][Full Text] [Related]
19. "Chronic" metastatic pancreatic acinar cell carcinoma.
Cananzi FC; Jayanth A; Lorenzi B; Belgaumkar A; Mochlinski K; Sharma A; Mudan S; Cunningham D
Pancreatology; 2013; 13(5):549-52. PubMed ID: 24075523
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.
Kieler M; Unseld M; Wojta J; Kaider A; Bianconi D; Demyanets S; Prager GW
Med Oncol; 2018 Nov; 36(1):1. PubMed ID: 30426271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
